Studies have revealed that SCF/c-kit signaling exclusively enhances CLDN3 expression in colorectal cancer, mainly by activating the JNK pathway, and that the SCF/c-kit-JNK-AP-1 signaling axis is crucial for controlling CLDN3 expression (33). Here, KIT is linked to colorectal cancer.